
Phraxis Announces First-Ever Commercial Case of EndoForce Anastomotic Connector
The technology is compatible with all PTFE grafts and was studied extensively in the company’s pivotal clinical trial
The technology is compatible with all PTFE grafts and was studied extensively in the company’s pivotal clinical trial
Imperative Care announced today that the FDA granted 510(k) clearance for its Symphony thrombectomy system to treat pulmonary embolism (PE).
Medtronic (NYSE: MDT)+
today announced major regulatory milestones for its MiniMed 780G automated insulin delivery system.
Measurements with a miniature camera inside the coronary arteries can accurately predict whether someone will suffer a recurrent heart attack. Until now, interpreting these images was so complex that only specialized laboratories could perform it.
A simple blood test could make asthma treatment more precise, more effective—and potentially more affordable. Researchers from Karl Landsteiner University of Health Sciences (KL Krems) and the Medical University of Vienna (MedUni Vienna) have developed a molecular allergy chip that detects allergic asthma in individual patients.
Concerned about the ability of artificial intelligence models trained on data from urban demographics to make the right medical diagnoses for rural populations, West Virginia University computer scientists have developed several AI models that can identify signs of heart failure in patients from Appalachia.
An AI-enabled stethoscope can help doctors pick up three heart conditions in just 15 seconds, according to the results of a real-world trial presented at the European Society of Cardiology’s annual congress in Madrid.
Professor Deng Hongkui’s team from the Peking University School of Life Sciences has made the first successful differentiation of human pluripotent stem cells into fully endocrine-subtype-complete islets.
A research team has used multi-emission metal organic framework hydrogel (Eu-Dy MOF gel) to construct a noninvasive wearable eye patch fluorescence sensor, combined with the color recognition function of a smartphone to analyze and monitor lysozyme in tears.
A research team has successfully developed the world’s first nasal organoid-based SARS-CoV-2 neutralizing antibody evaluation platform.